8OMV image
Entry Detail
PDB ID:
8OMV
Keywords:
Title:
Crystal structure of the constitutively active S117E/S181E mutant of human IKK2
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2023-03-31
Release Date:
2024-04-10
Method Details:
Experimental Method:
Resolution:
4.16 Å
R-Value Free:
0.29
R-Value Work:
0.25
R-Value Observed:
0.25
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Inhibitor of nuclear factor kappa-B kinase subunit beta
Mutations:S177E, S181E
Chain IDs:A, B, C, D, E
Chain Length:671
Number of Molecules:5
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation

Abstact

The inhibitor of κB (IκB) kinase (IKK) is a central regulator of NF-κB signaling. All IKK complexes contain hetero- or homodimers of the catalytic IKKβ and/or IKKα subunits. Here, we identify a YDDΦxΦ motif, which is conserved in substrates of canonical (IκBα, IκBβ) and alternative (p100) NF-κB pathways, and which mediates docking to catalytic IKK dimers. We demonstrate a quantitative correlation between docking affinity and IKK activity related to IκBα phosphorylation/degradation. Furthermore, we show that phosphorylation of the motif's conserved tyrosine, an event previously reported to promote IκBα accumulation and inhibition of NF-κB gene expression, suppresses the docking interaction. Results from integrated structural analyzes indicate that the motif binds to a groove at the IKK dimer interface. Consistently, suppression of IKK dimerization also abolishes IκBα substrate binding. Finally, we show that an optimized bivalent motif peptide inhibits NF-κB signaling. This work unveils a function for IKKα/β dimerization in substrate motif recognition.

Legend

Protein

Chemical

Disease

Primary Citation of related structures